Company Filing History:
Years Active: 2008-2013
Introduction
Simon J Evans, a notable inventor based in Milan, MI, has made significant strides in the field of neuropsychiatric research. With three patents to his name, Evans's work focuses on innovative approaches to diagnosing and treating mental disorders, showcasing his commitment to advancing mental health care.
Latest Patents
Evans's latest inventions include:
1. **Administration of FGF2 for Treatment of Anxiety**: This patent provides methods for diagnosing mental disorders and identifies modulators of these disorders. The invention also outlines ways to use these modulators to effectively treat patients suffering from anxiety-related conditions.
2. **Compositions and Methods for Diagnosing and Treating Neuropsychiatric Disorders**: This patent outlines methods for diagnosing various mental disorders, including psychotic disorders like schizophrenia and mood disorders such as major depressive disorder and bipolar disorder. Similar to his previous invention, it also suggests novel ways to identify modulators that can assist in the treatment of these conditions.
Career Highlights
Simon J Evans is associated with Leland Stanford Junior University, where he continues his research and innovation in neuropsychiatry. His contributions not only include his own patents but also influence the academic and medical communities as he collaborates with other experts in the field.
Collaborations
Throughout his career, Evans has worked alongside esteemed colleagues such as Huda Akil and Prabhakara V Choudary. These collaborations highlight the importance of teamwork in advancing research in mental health and developing viable solutions for patients.
Conclusion
With a focus on diagnosing and treating mental disorders, Simon J Evans's contributions to the field of neuropsychiatry through his patents are invaluable. His ongoing work at Leland Stanford Junior University, along with his collaborations, positions him as a key innovator striving to improve mental health outcomes for individuals affected by these challenging conditions.